CJC-1295 (no DAC) 30mg
$199.00
MOD-GRF (1-29) / CJC-1295 (No DAC) offers a focused tool for researchers studying pathways related to growth-hormone–adjacent signaling and peptide stability. A minimal, precise sequence designed for controlled in-vitro exploration.
All products are sold strictly for laboratory and research applications. They are not approved for human or animal use. No medical, diagnostic, or therapeutic claims are made or implied.
- Description
- Certificate of Analysis
- Store Policies
- Inquiries
Description
MOD-GRF (1-29) / CJC-1295 (No DAC) reflects a streamlined approach to peptide research. The sequence is structured to allow controlled investigation into growth-hormone–related pathways, receptor engagement, and peptide fragmentation patterns often discussed in preclinical literature.
Research Overview
Studies examine how truncated analogs such as MOD-GRF (1-29) interact with GHRH-related receptors, while CJC-1295 (No DAC) is frequently referenced in the context of in-vitro stability and chain modification considerations. Together, they offer a platform for researchers exploring comparative peptide behavior under defined laboratory conditions.
Key Research Areas Commonly Discussed
- Preclinical exploration of GHRH-pathway interactions
- In-vitro comparison of analog structure and degradation dynamics
- Assessment of receptor-adjacent signaling models
- Evaluation of sequence modifications and their impact on stability in controlled settings
For laboratory research only. Educational reference only.
Certificate of Analysis
Certificates of Analysis will be published here as they’re finalized and uploaded. Check back soon for the latest documentation.
General Inquiries
There are no inquiries yet.
Reviews
There are no reviews yet